FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
PhRMA Perspective on Clinical Pharmacology Research in Pregnant Women
Overview
The Problem
What Possibilities Does Clinical Pharmacology Hold?
What are the Limitations?
What are the Limitations? (continued)
Industry Concerns
Which Drugs Should be Studied?
When in a Drug’s Lifecycle Should it be Studied?
When in a Drug’s Lifecycle Should it be Studied? (continued)
Who Should be Studied & When?
What Information Should be Obtained?
How Should Studies be Designed and Data Analyzed & Communicated?
Possibilities for the Future
Possibilities for the Future (continued)
Summary
Summary (continued)
The Ideal Goal
Director, Clinical Pharmacology/Experimental Medicine, Bristol-Myers Squibb
Download presentation source
Last update: July 11, 2005
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research
